BNTC — Benitec Biopharma Cashflow Statement
0.000.00%
Last trade - 00:00
- $12.83m
- -$7.54m
- $0.08m
- 13
- 18
- 97
- 38
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | 10-K | 10-K | 10-K | 10-K |
Standards: | IFRS | USG | USG | USG | USG |
Status: | fx Final | Final | Final | Final | Final |
Changes in Working Capital | 4.19 | -7.54 | -12.8 | -15.9 | -18 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 4.19 | -7.54 | -12.8 | -15.9 | -18 |
Capital Expenditures | -0.412 | -0.095 | -0.221 | -0.013 | -0.001 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.004 | 0.001 | 0 | — | — |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.408 | -0.094 | -0.221 | -0.013 | -0.001 |
Financing Cash Flow Items | 0 | -0.48 | -3.23 | 0 | -1.87 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 0 | 1.77 | 22.5 | 0 | 16 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 4.52 | -5.92 | 9.97 | -15.7 | -1.59 |